Dermot Mee

Chief Revenue Officer

Dermot is a revenue and growth expert, driving excellence in business operations as a tool for rapid growth.  At Linqto Dermot leads a cross functional team focused on scaling the company’s initial success to new heights.  Dermot began his career as a biochemist with Schering-Plough Pharmaceuticals in their state-of-the-art bio-manufacturing facility in Cork Ireland. After moving to California in 1994, Dermot quickly transitioned from the laboratory to operations and project management with Syntex, Roche, and Yamanouchi.  Dermot’s commitment to the impact of process re-engineering was strengthened during his leadership of the automation of the monoclonal antibody production process at Medarex (acquired by Bristol-Myers Squibb in 2008), combining process re-engineering, custom software development, integration, and massive change management to allow four technicians to revolutionize the R&D process for monoclonal antibody product development. Dermot joined Singularity University (SU) in 2016.  Leveraging rapid prototyping, experimentation, and customer-focused development to build dynamic tools and interfaces. Dermot created the infrastructure and operational effectiveness needed to scale SU’s global community of customers, experts, and partners. Dermot led the company through the painful pandemic during which he made many difficult decisions required to save the business and subsequently lead the recovery, recapitalization and stabilization of Singularity. Dermot received his B.S. and M.S. degrees in Biochemistry from National University of Ireland Galway (Ireland) and his MBA from Pepperdine University, California USA.